New investment will progress treatment of pulmonary arterial hypertension (PAH), a rare condition which causes high blood pressure in the blood vessels that supply the lungs and can lead to heart failure. Current approved medications mainly ...
Members of the PH Community will come together on May 5 to raise awareness, support one another and advocate for PH. SILVER SPRING, Md. , April 18, 2022 /PRNewswire-PRWeb/ -- The Pulmonary Hypertension Association (PHA) joins more ...
ATHENS, Ga. , March 3, 2022 /PRNewswire/ -- Athena Bioscience, LLC announced plans for the commercial launch of Nexiclon XR, the only once-daily clonidine extended-release tablets indicated for treatment of hypertension. 1 Athena ...
Team PHenomenal Hope reopens its research fund. BELOIT, Wis. , Jan. 12, 2022 /PRNewswire-PRWeb/ -- Team PHenomenal Hope (Team PH), a nonprofit organization, has announced the reopening of their research fund, the PHenomenal Impact Fund for ...
The Pulmonary Hypertension Association's Spark Awareness campaign strives to educate people about pulmonary hypertension. SILVER SPRING, Md. , Oct. 21, 2021 /PRNewswire-PRWeb/ -- Each November, the Pulmonary Hypertension Association (PHA) ...
NetworkNewsWire Editorial Coverage NEW YORK , Sept. 14, 2021 /PRNewswire/ -- Hypertension, or high blood pressure, is rampant in America. An estimated 45% of adults in the United States , or 108 million people, have hypertension, yet only ...
Non-profit's second annual town hall will focus on "Living With Pulmonary Hypertension Beyond the Pandemic." BELOIT, Wis. , July 13, 2021 /PRNewswire-PRWeb/ -- Nonprofit Team PHenomenal Hope (Team PH) will announce the 2021 winner of the ...
First pivotal study of Tyvaso® (treprostinil) Inhalation Solution outside pulmonary hypertension SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , June 3, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced ...
PALO ALTO, Calif. , May 16, 2021 /PRNewswire/ -- ReCor Medical, Inc. ("ReCor"), a wholly-owned subsidiary of Otsuka Medical Devices Co., Ltd., today presented the primary endpoint data from the randomized sham-controlled RADIANCE-HTN TRIO ...
In this free webinar, the featured speaker will discuss the approach to defining an off-target increase in blood pressure for a developing compound and differentiate between the devices available for assessing BP in clinical trials. The ...
Systolic blood pressure , representing arterial pressure during heartbeats, emerged as a pivotal predictor of stroke risk among Type 2 diabetes mellitus patients ...
Getting less than seven hours of sleep is linked to an increased likelihood of developing high blood pressure in the long run. Sleeping less than seven hours was linked to a 7%...
Combining two or more blood pressure medications can markedly lower blood pressure in patients on ibrutinib. ( ) Targeted drugs such as ibrutinib have improved outcomes for patients with cancers of the lymphatic system, but patients treated ...
Group of international experts advocates for a crucial change in hypertension treatment guidelines, urging the inclusion of recommendations for low-sodium potassium-enriched salt to enhance high blood pressure control as published in the American ...
A group of researchers has uncovered a method for forecasting individuals likely to respond positively to blood pressure treatments aimed at reducing body sodium levels . ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers